biomedicina slovenica

re="Eur J Cancer" : 101-137

  1. Berrino F; Gatta G; Sant M; Capocaccia R; Oberaigner W; Storm H; Aareleid T; Hakulinen T; Hedelin G; Pompe-Kirn V
    The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses
    2001 ►
  2. Pleško I; Kramarova E; Stiller CA; Coebergh J-W; Santaquilani M
    Survival of children with Wilms' tumour in Europe
    2001 ►
  3. Bešić N; Rener M; Frković-Grazio S; Lindtner J; Žgajnar J; Gažić B
    Breast biopsy with needle localization: factors influencing complete excision of nonpalpable carcinoma
    2000 ►
  4. Awada A; Nooij M; Biganzoli L; Čufer T; Beek L; Batter V; Piccart MJ
    A phase I study of continuous infusion 5-fluorouracil (F-intu) in combination with gemcitabine (GEM) in patients (pts) with anthracycline- (A) refractory or A- and taxane- (T) pretreated metastatic breast cancer (MBC)
    2000 ►
  5. Uršič-Vrščaj M
    HRT in women with a history of breast cancer
    2000 ►
  6. Majdič E; Paulin-Košir S
    Locoregional control in breast cancer patients treated with mastectomy - is postoperative radiotherapy necessary?
    2000 ►
  7. Biganzoli L; Čufer T; Fargeot P; Rapoport B; Nooij M; Duchateau L; van Hoorebeeck I; Yague C; Epelbaum R; Piccart M
    Doxorubicin (A)/taxol (T): a safe regimen in terms of cardiac toxicity in the contex of an EORTC multicenter trial
    2000 ►
  8. Vegelj-Pirc M; Škufca AC; Zalokar-Divjak Z; Purić F
    Psychological consequences of breast cancer on family life
    2000 ►
  9. Jagodic M; Zakotnik B; Golouh R; Červek J; Čufer T
    Response to oral etoposide in advanced breast cancer: correlation with expression of c-erbB-2 protein
    2000 ►
  10. Bobnar A; Velepič M
    Safe handling of cytotoxic drugs in Slovenia
    1999 ►
  11. Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Lichinitser R; Pluzanska A; Tomiak E; Koopmanschap M; Piccart M
    The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study: results of an EORTC-NCIC-SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)
    1999 ►
  12. Malik I; Roth A; Ghilezan N; Čufer T; Lazarev A; Doval D; Ionescu-Goga S; Chernozemsky I; Quinaux E; Chirina N
    A phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (PTS) with metastatic breast cancer (mbc) with stratification according to prognosis factors
    1999 ►
  13. Bajetta E; Dirix LY; Fein LE; Jones SE; Červek J; Kaufmann M; Fowst C; Polli A; di Salle E; Massimini G
    Survival advantage of exemestane (EXE, aromasin) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study
    1999 ►
  14. Uršič H; Šalehar A
    Use of alginate dressings in the care of chronic wound
    1999 ►
  15. Bešić N; Auersperg M; Us-Krašovec M; Golouh R; Brecelj E
    Primary treatment and survival in anaplastic thyroid carcinoma
    1999 ►
  16. Alexander FE; Boyle P; Carli P-M; Coebergh JW; Ekbom A; Levi F; McKinney PA; McWhirter W; Michaelis J; Pompe-Kirn V
    Population density and childhood leukemia: results of the EUROCLUS study
    1999 ►
  17. Serša G; Čemažar M; Parkins CS; Chaplin DJ
    Tumour blood flow changes induced by application of electric pulses
    1999 ►
  18. Pagani O; Eržen D; Cerar O; Štabuc B; Golouh R; Lamovec J; Šebek S; Kramberger M; Vrhovec I; et al ;
    Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer pateints with axillary node involvement: results of the International breast cancer study group (IBCSG) trial VI
    1998 ►
  19. Serša G; Štabuc B; Čemažar M; Jančar B; Miklavčič D; Rudolf Z
    Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients
    1998 ►
  20. Strojan P; Budihna M; Šmid L; Vrhovec I; Škrk J
    Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients
    1998 ►
  21. Edhemović I; Volk N; Auersperg M
    Second primary cancers following thyroid cancer in Slovenia. A population-based cohort study
    1998 ►
  22. Škrbinc B; Babič A; Us-Krašovec M
    Breast cancer grading in cell samples
    1998 ►
  23. Pagani O; O'Neil A; Castiglione M; Gelber RD; Goldhirsch A; Rudenstam C-M; Lindtner J; Collins J; Crivellari D; Coates A
    Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer pateints with axillary node involvement: results of the International breast cancer study group (IBCSG) trial VI
    1998 ►
  24. Vegelj-Pirc M; Zalokar-Divjak Z; Musek J; Purič F
    The meaning of life with women after breast cancer treatment
    1998 ►
  25. Vegelj-Pirc M; Snoj Z
    The influence of the early childhood family climate on later breast cancer morbidity
    1998 ►
  26. Južnič T; Čufer T; Borštnar S
    Male breast cancer: a 20 year review of 60 patients in Slovenia
    1998 ►
  27. Zwitter Matjaž; Čufer Tanja; Smrdel Uroš; Therasse Patrick
    Culture and communication: approach to patients in clinical research
    1998 ►
  28. Horiot JC; Bontemps P; Begg AC; Le Fur R; van der Bogaert W; Bolla M; Nguyen T; van der Weijngaert D; Bernier J; Jančar B; et al
    New radiotherapy fractionation schemes in head and neck cancers. The EOTC trials: a benchmark
    1997 ►
  29. Štabuc B; Ocvirk J; Plesničar A; Čurin V; Žunec P; Rožman P
    Increased serum levels of soluble receptor for tumours necrosis factor p-55 in melanoma patients
    1997 ►
  30. Lokajner G
    Individual nursing approach for patients with an I.A. hepatic access port
    1997 ►
  31. Bobnar A; Piškur J
    Prevention of extravasation during application of cytostatics via peripheral veins
    1997 ►
  32. Osmak M; Babić D; Abramić M; Vrhovec I; Miličić D; Škrk J
    Cathepsin D content in malignant tumours of corpus uteri
    1997 ►
  33. Macfarlane GJ; McCredie M; Pompe-Kirn V; Sharpe L; Coates M
    Second cancers occurring after cancers of the mouth and pharynx: data from three population-based registries in Australia, Scotland and Slovenia
    1995 ►
  34. Boyle P; Veronesi U; Tubiana M; Alexander FE; Calais da Silva F; Denis LJ; Freire JM; Hakama M; Hirsch A; Plesničar S
    European school of oncology advisory report to the European commission for the "Europe against cancer programme": European code against cancer
    1995 ►
  35. Budihna M; Škrk J; Zakotnik B; Gabrijelčič D; Lindtner J
    Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast
    1995 ►
  36. Williams CJ; Zwitter M
    Informed consent in European multicentre randomised clinical trials - are patients really informed?
    1994 ►
  37. Parkin DM; Cardis E; Masuyer E; Friedl HP; Hansluwka H; Bobev D; Ivanov E; Sinnaeve J; Augustin J; Pompe-Kirn V
    Childhood leukaemia following the Chernobyl accident: the European childhood leukemia-lymphoma incidence study (ECLIS)
    1993 ►

   1 101

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko